Yn dangos 1081 i 1095 o 2032 canlyniadau
Be visible, engaged and informed
Aim: We regulate, take and communicate decisions which are informed by a deep understanding of the environment within which our registrants, employers and education providers operate
Paramedics self-referral guidance and advice - webinar
Do you know when self-referral to the HCPC is appropriate? Learn more at this free webinar specially designed for paramedics.
Registrant snapshot - 4 February 2025
Total number of registrants for the HCPC Register, broken down by profession and application route to registration (4 February 2025).
Registrant snapshot - 1 December 2024
Total number of registrants for the HCPC Register, broken down by profession and application route to registration (1 December 2024).
Diversity data
Our dashboard shows key equality, diversity and inclusion (EDI) information with regards to the characteristics of HCPC registrants
Completing a CPD profile for audit
If selected for CPD audit, you'll be asked to submit a profile as proof of your activities and how they meet the standards for CPD
Student competition
Each year, we run a competition for students who, at the time of entry, are enrolled on an HCPC-approved pre-registration programme.
Standards
Our standards form the foundation for how we regulate, explaining what we expect of our registrants and education and training programmes.
Bringing profession into disrepute / inappropriate comments on social media
Case study: A paramedic self-referred after he posted inappropriate comments on social media, which caused his employer to suspend him.
Record keeping
You have a professional responsibility to keep full, clear and accurate records
Rhaglenni wedi’u cymeradwyo
Rydym yn dal cofrestr o’r holl raglenni wedi’u cymeradwyo sy’n bodloni’n Safonau ar gyfer y proffesiynau rydyn ni’n eu rheoleiddio.
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).